| Size | Price | |
|---|---|---|
| 500mg | ||
| 1g | ||
| Other Sizes |
| Targets |
APTO-253 isomer targets the metal-regulatory transcription factor 1 (MTF-1). It inhibits MTF-1 activity, which in turn induces the expression of the tumor suppressor factor Kruppel-like factor 4 (KLF4). It also stabilizes G-quadruplex DNA and reduces MYC mRNA expression.
|
|---|---|
| ln Vitro |
In vitro, APTO-253 isomer is a potent MTF-1 inhibitor with anticancer activity. It induces the expression of KLF4 and reduces MYC expression. Its activity is measured in cell-based assays, where it inhibits the proliferation of cancer cells.
|
| ln Vivo |
In vivo, APTO-253 isomer has potential antitumor activity. Its mechanism of inducing KLF4 and reducing MYC expression suggests it could be effective in animal models of cancer. Specific in vivo data are not detailed in the search results.
|
| Enzyme Assay |
The in vitro enzyme/receptor binding assay for APTO-253 isomer is not standard, as its mechanism involves transcription factor inhibition. Its effects on MTF-1 activity can be assessed by measuring the expression of MTF-1 target genes, such as KLF4, using qRT-PCR or Western blot.
|
| Cell Assay |
Cellular in vitro experiments for APTO-253 isomer are conducted using cancer cell lines. Cells are treated with the compound, and cell viability is assessed using MTT or similar assays. The expression of KLF4 and MYC is measured by Western blot or qRT-PCR to confirm the mechanism of action.
|
| Animal Protocol |
In vivo animal experiments for APTO-253 isomer would involve using mouse xenograft models of cancer. The compound would be administered, and tumor growth would be monitored. Tumors would be harvested for analysis of KLF4 and MYC expression to confirm target engagement.
|
| References |
|
| Molecular Formula |
C22H14FN5
|
|---|---|
| Molecular Weight |
367.378467082977
|
| Exact Mass |
367.123
|
| CAS # |
1422826-80-9
|
| Related CAS # |
1691221-67-6 (HCl);916151-99-0 (Free base);1422731-37-0 (APTO-253 isomer HCl);1422826-80-9 (APTO-253 isomer free base);
|
| PubChem CID |
71263684
|
| Appearance |
Typically exists as solid at room temperature
|
| LogP |
4.3
|
| tPSA |
70.2
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
4
|
| Rotatable Bond Count |
1
|
| Heavy Atom Count |
28
|
| Complexity |
589
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
N1C2C(=C3NC(C4C5=C(NC=4C)C=C(F)C=C5)=NC3=C3C=2N=CC=C3)C=CC=1
|
| InChi Key |
ZBMZAZLIAFTXRO-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C22H14FN5/c1-11-17(13-7-6-12(23)10-16(13)26-11)22-27-20-14-4-2-8-24-18(14)19-15(21(20)28-22)5-3-9-25-19/h2-10,26H,1H3,(H,27,28)
|
| Chemical Name |
2-(6-fluoro-2-methyl-1H-indol-3-yl)-1H-imidazo[4,5-f][1,10]phenanthroline
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.7220 mL | 13.6099 mL | 27.2198 mL | |
| 5 mM | 0.5444 mL | 2.7220 mL | 5.4440 mL | |
| 10 mM | 0.2722 mL | 1.3610 mL | 2.7220 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.